Saxagliptin Hydrochloride Dihydrate is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor used primarily as an oral antihyperglycemic agent for the management of type 2 diabetes mellitus. By inhibiting… Read more
Saxagliptin Hydrochloride Dihydrate is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor used primarily as an oral antihyperglycemic agent for the management of type 2 diabetes mellitus. By inhibiting the DPP-4 enzyme, this medication prolongs the activity of incretin hormones, thereby increasing insulin secretion and decreasing glucagon levels in a glucose-dependent manner. To ensure the safety and efficacy of this active pharmaceutical ingredient, laboratories rely on a comprehensive range of high-quality reference materials. This category includes pharmacopeial and non-pharmacopeial impurities, specific metabolites, and stable isotope labelled compounds essential for rigorous impurity profiling, method validation, and routine quality control. Access to these precise analytical standards allows researchers and quality assurance teams to conduct accurate quantification and identification, ensuring compliance with regulatory requirements throughout the drug development and manufacturing lifecycle.